RANKL expression in periodontal disease: Where does RANKL Come from?

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chen, Bin ^a   Wu, Wenlei ^a   Sun, Weibin ^a   Zhang, Qian ^a   Yan, Fuhua ^a   Xiao, Yin ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFSF11 PROTEIN, HUMAN;

B LYMPHOCYTE; FIBROBLAST; GINGIVA; HUMAN; MACROPHAGE; OSTEOLYSIS; PERIODONTAL DISEASE; PERIODONTITIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TH2 CELL; ALVEOLAR BONE LOSS; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; METABOLISM; OSTEOCLAST; PATHOLOGY;

ALVEOLAR BONE LOSS; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; OSTEOCLASTS; RANK LIGAND;

EID: 84897836170     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/731039     Document Type: Review

References (60)

1. Nagasawa T., Kiji M., Yashiro R., Hormdee D., Lu H., Kunze M., Suda T., Koshy G., Kobayashi H., Oda S., Nitta H., Ishikawa I., Roles of receptor activator of nuclear factor- B ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontology 2000 2007 43 1 65 84 2-s2.0-33846091717 10.1111/j.1600-0757.2006.00185.x
2. Udagawa N., Takahashi N., Jimi E., Matsuzaki K., Tsurukai T., Itoh K., Nakagawa N., Yasuda H., Goto M., Tsuda E., Higashio K., Gillespie M. T., Martin T. J., Suda T., Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor. Bone 1999 25 5 517 523 2-s2.0-0032854699 10.1016/S8756-3282(99)00210-0 (Pubitemid 29469457)
3. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M. T., Martin T. J., Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Reviews 1999 20 3 345 357 2-s2.0-0033304730 (Pubitemid 30649812)
4. Lacey D. L., Timms E., Tan H.-L., Kelley M. J., Dunstan C. R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y.-X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., Boyle W. J., Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998 93 2 165 176 2-s2.0-0032540319 10.1016/S0092-8674(00)81569-X (Pubitemid 28180851)
5. Walsh N. C., Alexander K. A., Manning C. A., Karmakar S. K., Wang J. F., Weyand C. M., Pettit A. R., Gravallese E. M., Activated human T cells express alternative mRNA transcripts encoding a secreted form of RANKL. Genes & Immunity 2013 14 4 336 345
6. Wara-Aswapati N., Surarit R., Chayasadom A., Boch J. A., Pitiphat W., RANKL upregulation associated with periodontitis and porphyromonas gingivalis. Journal of Periodontology 2007 78 6 1062 1069 2-s2.0-34347334369 10.1902/jop.2007.060398
7. Jin Q., Cirelli J. A., Park C. H., Sugai J. V., Taba M. Jr., Kostenuik P. J., Giannobile W. V., RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. Journal of Periodontology 2007 78 7 1300 1308 2-s2.0-34547481944 10.1902/jop.2007.070073
8. Napimoga M. H., Benatti B. B., Lima F. O., Alves P. M., Campos A. C., Pena-dos-Santos D. R., Severino F. P., Cunha F. Q., Guimarães F. S., Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. International Immunopharmacology 2009 9 2 216 222 2-s2.0-58249144544 10.1016/j.intimp.2008.11.010
9. Fukushima H., Jimi E., Okamoto F., Motokawa W., Okabe K., IL-1-induced receptor activator of NF- B ligand in human periodontal ligament cells involves ERK-dependent PGE2 production. Bone 2005 36 2 267 275 2-s2.0-14144249792 10.1016/j.bone.2004.09.011 (Pubitemid 40283583)
10. Kawai T., Matsuyama T., Hosokawa Y., Makihira S., Seki M., Karimbux N. Y., Goncalves R. B., Valverde P., Dibart S., Li Y., Miranda L. A., Ernst C. W. O., Izumi Y., Taubman M. A., B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. American Journal of Pathology 2006 169 3 987 998 2-s2.0-33748788554 10.2353/ajpath.2006.060180 (Pubitemid 44411961)
11. Liu D., Xu J. K., Figliomeni L., Huang L., Pavlos N. J., Rogers M., Tan A., Price P., Zheng M. H., Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. International Journal of Molecular Medicine 2003 11 1 17 21 2-s2.0-0345147090
12. Kawai T., Shimauchi H., Eastcott J. W., Smith D. J., Taubman M. A., Antigen direction of specific T-cell clones into gingival tissues. Immunology 1998 93 1 11 19 2-s2.0-0031952423 10.1046/j.1365-2567.1998.00408.x (Pubitemid 28133090)
13. Kawai T., Eisen-Lev R., Seki M., Eastcott J. W., Wilson M. E., Taubman M. A., Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. Journal of Immunology 2000 164 4 2102 2109 2-s2.0-0034651568 (Pubitemid 30108769)
14. Taubman M. A., Kawai T., Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Critical Reviews in Oral Biology and Medicine 2001 12 2 125 135 2-s2.0-0035021269 (Pubitemid 32429279)
15. Valverde P., Kawai T., Taubman M. A., Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. Journal of Bone and Mineral Research 2004 19 1 155 164 2-s2.0-2142843025 10.1359/JBMR.0301213 (Pubitemid 41295148)
16. Teng Y. A., Nguyen H., Gao X., Kong Y., Gorczynski R. M., Singh B., Ellen R. P., Penninger J. M., Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. The Journal of Clinical Investigation 2000 106 6 R59 R67 2-s2.0-0033805254
17. Kawai T., Paster B. J., Komatsuzawa H., Ernst C. W. O., Goncalves R. B., Sasaki H., Ouhara K., Stashenko P. P., Sugai M., Taubman M. A., Cross-reactive adaptive immune response to oral commensal bacteria results in an induction of receptor activator of nuclear factor- B ligand (RANKL)-dependent periodontal bone resorption in a mouse model. Oral Microbiology and Immunology 2007 22 3 208 215 2-s2.0-34247876099 10.1111/j.1399-302X.2007.00348.x (Pubitemid 46691094)
18. Baker P. J., Dixon M., Evans R. T., Dufour L., Johnson E., Roopenian D. C., CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infection and Immunity 1999 67 6 2804 2809 2-s2.0-0032986491 (Pubitemid 29244693)
19. Vernal R., Dutzan N., Hernández M., Chandía S., Puente J., León R., García L., Del Valle I., Silva A., Gamonal J., High expression levels of receptor activator of nuclear factor-kappa B ligand associated with human chronic periodontitis are mainly secreted by CD4(+) T lymphocytes. Journal of Periodontology 2006 77 10 1772 1780 2-s2.0-33750581476 10.1902/jop.2006.050376 (Pubitemid 44680243)
20. Kamiya S., Okumura M., Chiba Y., Fukawa T., Nakamura C., Nimura N., Mizuguchi J., Wada S., Yoshimoto T., IL-27 suppresses RANKL expression in CD4(+) T cells in part through STAT3. Immunology Letters 2011 138 1 47 53 2-s2.0-79957694768 10.1016/j.imlet.2011.02.022
21. Gemmell E., Yamazaki K., Seymour G. J., The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontology 2000 2007 43 1 14 40 2-s2.0-33846045743 10.1111/j.1600-0757.2006.00173.x
22. Gao Y., Grassi F., Ryan M. R., Terauchi M., Page K., Yang X., Weitzmann M. N., Pacifici R., IFN- γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. The Journal of Clinical Investigation 2007 117 1 122 132 2-s2.0-33845981069 10.1172/JCI30074 (Pubitemid 46048459)
23. Gaffen S. L., Hajishengallis G., A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. Journal of Dental Research 2008 87 9 817 828 2-s2.0-52649128246 10.1177/154405910808700908
24. Cardoso C. R., Garlet G. P., Crippa G. E., Rosa A. L., Júnior W. M., Rossi M. A., Silva J. S., Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiology and Immunology 2009 24 1 1 6 2-s2.0-57649215597 10.1111/j.1399-302X.2008.00463.x
25. Ohyama H., Kato-Kogoe N., Kuhara A., Nishimura F., Nakasho K., Yamanegi K., Yamada N., Hata M., Yamane J., Terada N., The involvement of IL-23 and the Th 17 pathway in periodontitis. Journal of Dental Research 2009 88 7 633 638 2-s2.0-68249143144 10.1177/0022034509339889
26. Kramer J. M., Gaffen S. L., Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. Journal of Periodontology 2007 78 6 1083 1093 2-s2.0-34147150928 10.1902/jop.2007.060392
27. Yu J. J., Ruddy M. J., Wong G. C., Sfintescu C., Baker P. J., Smith J. B., Evans R. T., Gaffen S. L., An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 2007 109 9 3794 3802 2-s2.0-34147126728 10.1182/blood-2005-09-010116 (Pubitemid 46641730)
28. Yu J. J., Ruddy M. J., Conti H. R., Boonanantanasarn K., Gaffen S. L., The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss. Infection and Immunity 2008 76 9 4206 4213 2-s2.0-51949097521 10.1128/IAI.01209-07
29. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., Tanaka S., Kodama T., Akira S., Iwakura Y., Cua D. J., Takayanagi H., Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. Journal of Experimental Medicine 2006 203 12 2673 2682 2-s2.0-33751521013 10.1084/jem.20061775 (Pubitemid 44833343)
30. Ernst C. W. O., Lee J. E., Nakanishi T., Karimbux N. Y., Rezende T. M. B., Stashenko P., Seki M., Taubman M. A., Kawai T., Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor- B ligand (RANKL+) T cells in bone resorption lesion of periodontal disease. Clinical and Experimental Immunology 2007 148 2 271 280 2-s2.0-34247139294 10.1111/j.1365-2249.2006.03318.x (Pubitemid 46587581)
31. Han X., Kawai T., Eastcott J. W., Taubman M. A., Bacterial-responsive B lymphocytes induce periodontal bone resorption. Journal of Immunology 2006 176 1 625 631 2-s2.0-29644446802 (Pubitemid 43023311)
32. Han X., Lin X., Seliger A. R., Eastcott J., Kawai T., Taubman M. A., Expression of receptor activator of nuclear factor- B ligand by B cells in response to oral bacteria. Oral Microbiology and Immunology 2009 24 3 190 196 2-s2.0-67449137943 10.1111/j.1399-302X.2008.00494.x
33. Han X., Kawai T., Taubman M. A., Toll-like receptor signaling in B cell-mediated RANKL-dependent periodontitis bone resorption. Interface Oral Health Science 2011 Springer Japan 373 375
34. Fumoto T., Takeshita S., Ito M., Ikeda K., Physiological functions of osteoblast lineage and T cell-derived RANKL in bone homeostasis. Journal of Bone and Mineral Research 2013 10.1002/jbmr.2096
35. Atkins G. J., Kostakis P., Pan B., Farrugia A., Gronthos S., Evdokiou A., Harrison K., Findlay D. M., Zannettino A. C. W., RANKL expression is related to the differentiation state of human osteoblasts. Journal of Bone and Mineral Research 2003 18 6 1088 1098 2-s2.0-0142059624 10.1359/jbmr.2003.18.6.1088 (Pubitemid 37294947)
36. Nakashima T., Hayashi M., Fukunaga T., Kurata K., Oh-Hora M., Feng J. Q., Bonewald L. F., Kodama T., Wutz A., Wagner E. F., Penninger J. M., Takayanagi H., Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nature Medicine 2011 17 10 1231 1234 2-s2.0-80053938104 10.1038/nm.2452
37. Xiong J., O'Brien C. A., Osteocyte RANKL: new insights into the control of bone remodeling. Journal of Bone and Mineral Research 2012 27 3 499 505 2-s2.0-84857311721 10.1002/jbmr.1547
38. Xiong J., Onal M., Jilka R. L., Weinstein R. S., Manolagas S. C., O'Brien C. A., Matrix-embedded cells control osteoclast formation. Nature Medicine 2011 17 10 1235 1241 2-s2.0-80053978532 10.1038/nm.2448
39. Gordon S., Pattern recognition receptors: doubling up for the innate immune response. Cell 2002 111 7 927 930 2-s2.0-0037184995 10.1016/S0092- 8674(02)01201-1 (Pubitemid 36044685)
40. Heine H., Lien E., Toll-like receptors and their function in innate and adaptive immunity. International Archives of Allergy and Immunology 2003 130 3 180 192 2-s2.0-0037232254 10.1159/000069517 (Pubitemid 36362002)
41. Hajishengallis G., Toll gates to periodontal host modulation and vaccine therapy. Periodontology 2000 2009 51 1 181 207 2-s2.0-69149086044 10.1111/j.1600-0757.2009.00304.x
42. Burns E., Bachrach G., Shapira L., Nussbaum G., Cutting edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. Journal of Immunology 2006 177 12 8296 8300 2-s2.0-33845462504 (Pubitemid 44893789)
43. Kim K., Cho M., Lee S., Oh H., Kang C., Ju J. H., Min S., Cho Y., Park S., Kim H., Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunology Letters 2007 110 1 54 64 2-s2.0-34247881945 10.1016/j.imlet.2007.03.004 (Pubitemid 46695759)
44. Ukai T., Yumoto H., Gibson F. C. III, Genco C. A., Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires toll-like receptor 2-dependent tumor necrosis factor-alpha production. Infection and Immunity 2008 76 2 812 819 2-s2.0-39149116741 10.1128/IAI.01241-07 (Pubitemid 351251754)
45. Rosen G., Sela M. N., Naor R., Halabi A., Barak V., Shapira L., Activation of murine macrophages by lipoprotein and lipooligosaccharide of Treponema denticola. Infection and Immunity 1999 67 3 1180 1186 2-s2.0-0033014671 (Pubitemid 29108492)
46. Nussbaum G., Ben-Adi S., Genzler T., Sela M., Rosen G., Involvement of toll-like receptors 2 and 4 in the innate immune response to Treponema denticola and its outer sheath components. Infection and Immunity 2009 77 9 3939 3947 2-s2.0-69049092753 10.1128/IAI.00488-09
47. Schröder N. W. J., Meister D., Wolff V., Christan C., Kaner D., Haban V., Purucker P., Hermann C., Moter A., Göbel U. B., Schumann R. R., Chronic periodontal disease is associated with single-nucleotide polymorphisms of the human TLR-4 gene. Genes and Immunity 2005 6 5 448 451 2-s2.0-23444437867 10.1038/sj.gene.6364221 (Pubitemid 43090522)
48. Folwaczny M., Glas J., Török H.-P., Limbersky O., Folwaczny C., Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clinical and Experimental Immunology 2004 135 2 330 335 2-s2.0-0842265493 10.1111/j.1365-2249.2004.02383.x (Pubitemid 38177975)
49. Baer M. T., Huang N., Gibson F. C. III, Scavenger receptor A is expressed by macrophages in response to Porphyromonas gingivalis, and participates in TNF- α expression. Oral Microbiology and Immunology 2009 24 6 456 463 2-s2.0-70350026188 10.1111/j.1399-302X.2009.00538.x
50. Wei S., Kitaura H., Zhou P., Ross F. P., Teitelbaum S. L., IL-1 mediates TNF-induced osteoclastogenesis. The Journal of Clinical Investigation 2005 115 2 282 290 2-s2.0-14944371405 10.1172/JCI200523394 (Pubitemid 40385470)
51. O' Gradaigh D., Ireland D., Bord S., Compston J. E., Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor α interleukin 1, and receptor activator of nuclear factor B ligand (RANKL) regulate osteoclasts. Annals of the Rheumatic Diseases 2004 63 4 354 359 2-s2.0-1842505684 10.1136/ard.2003.008458 (Pubitemid 38453299)
52. Suda K., Udagawa N., Sato N., Takami M., Itoh K., Woo J., Takahashi N., Nagai K., Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation. Journal of Immunology 2004 172 4 2504 2510 2-s2.0-0842343433 (Pubitemid 38182401)
53. Assuma R., Oates T., Cochran D., Amar S., Graves D. T., IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. Journal of Immunology 1998 160 1 403 409 2-s2.0-0031908674 (Pubitemid 28116755)
54. Graves D. T., Oskoui M., Volejnikova S., Naguib G., Cai S., Desta T., Kakouras A., Jiang Y., Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. Journal of Dental Research 2001 80 10 1875 1879 2-s2.0-0034767683 (Pubitemid 33038053)
55. Xiao Y., Bunn C. L., Bartold P. M., Effect of lipopolysaccharide from periodontal pathogens on the production of tissue plasminogen activator and plasminogen activator inhibitor 2 by human gingival fibroblasts. Journal of Periodontal Research 2001 36 1 25 31 2-s2.0-0035259523 (Pubitemid 33644627)
56. Steeve K. T., Marc P., Sandrine T., Dominique H., Yannick F., IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine and Growth Factor Reviews 2004 15 1 49 60 2-s2.0-1642432081 10.1016/j.cytogfr.2003.10.005 (Pubitemid 38121290)
57. Garlet G. P., Martins W. Jr., Fonseca B. A. L., Ferreira B. R., Silva J. S., Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. Journal of Clinical Periodontology 2004 31 8 671 679 2-s2.0-4143063439 10.1111/j.1600-051X.2004.00545.x (Pubitemid 39092231)
58. Fujihara R., Usui M., Yamamoto G., Nishii K., Tsukamoto Y., Okamatsu Y., Sato T., Asou Y., Nakashima K., Yamamoto M., Tumor necrosis factor- α enhances RANKL expression in gingival epithelial cells via protein kinase A signaling. Journal of Periodontal Research 2013 10.1111/jre.12131
59. Wada N., Maeda H., Yoshimine Y., Akamine A., Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. Bone 2004 35 3 629 635 2-s2.0-4344644964 10.1016/j.bone.2004.04.023 (Pubitemid 39141863)
60. Vries T. J., Schoenmaker T., Wattanaroonwong N., van Hoonaard M. D., Nieuwenhuijse A., Beertsen W., Everts V., Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts. Journal of Cellular Biochemistry 2006 98 2 370 382 2-s2.0-33646124014 10.1002/jcb.20795